379 related articles for article (PubMed ID: 21703419)
21. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
22. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
23. PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription.
Wu K; Fan J; Zhang L; Ning Z; Zeng J; Zhou J; Li L; Chen Y; Zhang T; Wang X; Hsieh JT; He D
Cell Signal; 2012 Dec; 24(12):2273-82. PubMed ID: 22906492
[TBL] [Abstract][Full Text] [Related]
24. Involvement of ZEB1 and E-cadherin in the invasion of lung squamous cell carcinoma.
Zhang J; Lu C; Zhang J; Kang J; Cao C; Li M
Mol Biol Rep; 2013 Feb; 40(2):949-56. PubMed ID: 23065281
[TBL] [Abstract][Full Text] [Related]
25. Novel ZEB1 expression in bladder tumorigenesis.
Kenney PA; Wszolek MF; Rieger-Christ KM; Neto BS; Gould JJ; Harty NJ; Mosquera JM; Zeheb R; Loda M; Darling DS; Libertino JA; Summerhayes IC
BJU Int; 2011 Feb; 107(4):656-63. PubMed ID: 20735391
[TBL] [Abstract][Full Text] [Related]
26. The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism.
Chu K; Boley KM; Moraes R; Barsky SH; Robertson FM
Oncotarget; 2013 Mar; 4(3):446-62. PubMed ID: 23530113
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of thrombomodulin enhances HCC cell migration through increase of ZEB1 and decrease of E-cadherin gene expression.
Huang MT; Wei PL; Liu JJ; Liu DZ; Huey-Chun H; An J; Wu CC; Wu CH; Ho YS; Yang YY; Chang YJ
Ann Surg Oncol; 2010 Dec; 17(12):3379-85. PubMed ID: 20625840
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
[TBL] [Abstract][Full Text] [Related]
29. The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.
Tran MN; Choi W; Wszolek MF; Navai N; Lee IL; Nitti G; Wen S; Flores ER; Siefker-Radtke A; Czerniak B; Dinney C; Barton M; McConkey DJ
J Biol Chem; 2013 Feb; 288(5):3275-88. PubMed ID: 23239884
[TBL] [Abstract][Full Text] [Related]
30. SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer.
Sayan AE; Griffiths TR; Pal R; Browne GJ; Ruddick A; Yagci T; Edwards R; Mayer NJ; Qazi H; Goyal S; Fernandez S; Straatman K; Jones GD; Bowman KJ; Colquhoun A; Mellon JK; Kriajevska M; Tulchinsky E
Proc Natl Acad Sci U S A; 2009 Sep; 106(35):14884-9. PubMed ID: 19706487
[TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase-2 expression is related to the epithelial-to-mesenchymal transition in human colon cancers.
Jang TJ; Jeon KH; Jung KH
Yonsei Med J; 2009 Dec; 50(6):818-24. PubMed ID: 20046424
[TBL] [Abstract][Full Text] [Related]
32. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
33. Regulation of Proliferation and Epithelial-to-Mesenchymal Transition (EMT) of Gastric Cancer by ZEB1 via Modulating Wnt5a and Related Mechanisms.
Xue Y; Zhang L; Zhu Y; Ke X; Wang Q; Min H
Med Sci Monit; 2019 Mar; 25():1663-1670. PubMed ID: 30829316
[TBL] [Abstract][Full Text] [Related]
34. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells.
Tryndyak VP; Beland FA; Pogribny IP
Int J Cancer; 2010 Jun; 126(11):2575-83. PubMed ID: 19839049
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1.
Huang W; Zhang Y; Varambally S; Chinnaiyan AM; Banerjee M; Merajver SD; Kleer CG
Am J Pathol; 2008 Apr; 172(4):893-904. PubMed ID: 18321996
[TBL] [Abstract][Full Text] [Related]
36. Xihuang Pill () induces mesenchymal-epithelial transition and inhibits loss of apical-basal polarity in colorectal cancer cell through regulating ZEB1-SCRIB loop.
Wang M; Meng JY; He SF
Chin J Integr Med; 2014 Oct; 20(10):751-7. PubMed ID: 24802235
[TBL] [Abstract][Full Text] [Related]
37. Novel strategies to enforce an epithelial phenotype in mesenchymal cells.
Dragoi AM; Swiss R; Gao B; Agaisse H
Cancer Res; 2014 Jul; 74(14):3659-72. PubMed ID: 24845104
[TBL] [Abstract][Full Text] [Related]
38. Celecoxib induces epithelial-mesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expression.
Liu R; Zheng J; Li C; Pang Y; Zheng Q; Xu X; Liu P
Arch Gynecol Obstet; 2015 Jun; 291(6):1361-9. PubMed ID: 25424898
[TBL] [Abstract][Full Text] [Related]
39. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
Kong X; Ding X; Li X; Gao S; Yang Q
Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
[TBL] [Abstract][Full Text] [Related]
40. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
